Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- Check5 days agoChange DetectedA site-wide banner announces an NIH terminology transition and links to updates and FAQs, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedA 403 Forbidden page replaces the study content for NCT02781584, preventing access to the study details on ClinicalTrials.gov. The change reflects an access restriction rather than a data update.SummaryDifference23%

- Check61 days agoChange DetectedThe page's revision metadata now shows v3.6.6, replacing the previous v3.6.5, indicating an updated page build.SummaryDifference0.0%

- Check82 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a new version of the page template. This appears to be an administrative update and does not alter the displayed study information.SummaryDifference0.0%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.